| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M706978200 |
| P698 | PubMed publication ID | 17932034 |
| P2093 | author name string | Zhengxin Wang | |
| Edward T H Yeh | |||
| Jinke Cheng | |||
| Tasneem Bawa-Khalfe | |||
| P2860 | cites work | Differential regulation of sentrinized proteins by a novel sentrin-specific protease | Q22011173 |
| The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing | Q24553350 | ||
| SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1 | Q24563640 | ||
| Role of desumoylation in the development of prostate cancer | Q24676101 | ||
| Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA | Q27651364 | ||
| Characterization of the Localization and Proteolytic Activity of the SUMO-specific Protease, SENP1 | Q27863778 | ||
| Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. | Q27863917 | ||
| Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex | Q28142407 | ||
| Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity | Q28257118 | ||
| A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex | Q28275805 | ||
| Minireview: Cyclin D1: normal and abnormal functions | Q28279069 | ||
| Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium | Q28508802 | ||
| Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. | Q28589576 | ||
| Signal Transduction Mediated by Cyclin D1: from Mitogens to Cell Proliferation: A Molecular Target with Therapeutic Potential | Q29393789 | ||
| Two classes of androgen receptor elements mediate cooperativity through allosteric interactions | Q31514020 | ||
| National Comprehensive Cancer Network guidelines for the management of prostate cancer | Q34187291 | ||
| Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation | Q34268815 | ||
| Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors | Q34380370 | ||
| Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases | Q34392520 | ||
| Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells | Q35089374 | ||
| Gene regulation by Sp1 and Sp3. | Q35851299 | ||
| Regulation of androgen receptor signaling in prostate cancer | Q36066149 | ||
| Regulation of androgen receptor levels: implications for prostate cancer progression and therapy | Q36110677 | ||
| Androgen receptor and prostate cancer | Q36734752 | ||
| Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. | Q36888922 | ||
| Structural basis of androgen receptor binding to selective androgen response elements. | Q37414946 | ||
| The androgen axis in recurrent prostate cancer | Q39675435 | ||
| Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. | Q40084346 | ||
| Androgen deprivation increases p300 expression in prostate cancer cells | Q40149224 | ||
| Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells | Q40550455 | ||
| Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development | Q40651903 | ||
| Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 | Q41107142 | ||
| SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities | Q42816242 | ||
| Impact of differential cyclin D1 expression and localisation in prostate cancer | Q43153660 | ||
| Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. | Q44279178 | ||
| Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements | Q44805586 | ||
| The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain | Q45126345 | ||
| Predicting Pol II promoter sequences using transcription factor binding sites | Q48072762 | ||
| Determinants of DNA Sequence Specificity of the Androgen, Progesterone, and Glucocorticoid Receptors: Evidence for Differential Steroid Receptor Response Elements | Q58515340 | ||
| P433 | issue | 52 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 37341-37349 | |
| P577 | publication date | 2007-10-11 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells | |
| P478 | volume | 282 |
| Q39014919 | 15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1α expression in human colon cancer cells |
| Q35760146 | Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription |
| Q99571280 | Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer |
| Q39505892 | Detection of differentially expressed genes and association with clinicopathological features in laryngeal squamous cell carcinoma |
| Q38112122 | Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer |
| Q35996105 | ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors |
| Q34108064 | Emerging roles of SUMO modification in arthritis |
| Q37726325 | Emerging roles of the ubiquitin proteasome system in nuclear hormone receptor signaling |
| Q26991707 | Function and regulation of SUMO proteases |
| Q38256197 | Higher androgen bioactivity is associated with excessive erythrocytosis and chronic mountain sickness in Andean Highlanders: a review. |
| Q34308627 | Identification of the molecular basis of doxorubicin-induced cardiotoxicity |
| Q34299153 | Induction of SENP1 in Endothelial Cells Contributes to Hypoxia-driven VEGF Expression and Angiogenesis |
| Q37644806 | Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation |
| Q30847259 | Network analysis of ChIP-Seq data reveals key genes in prostate cancer |
| Q38364166 | Overview on the complexity of androgen receptor-targeted therapy for prostate cancer |
| Q27007098 | Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy |
| Q35842790 | Post-translational modifications of nuclear receptors and human disease |
| Q39254961 | Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy |
| Q37349403 | Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts |
| Q35380380 | Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications |
| Q34056043 | SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms |
| Q42109613 | SENP1 regulates PTEN stability to dictate prostate cancer development. |
| Q38894093 | SENP1 regulates cell migration and invasion in neuroblastoma |
| Q37820200 | SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression |
| Q39108925 | SUMO and the robustness of cancer |
| Q35769614 | SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle |
| Q30352713 | SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. |
| Q39325271 | SUMO-specific protease 1 promotes prostate cancer progression and metastasis |
| Q38956991 | SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. |
| Q37325310 | SUMOylation and De-SUMOylation: wrestling with life's processes |
| Q41417327 | SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy |
| Q37074734 | Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer |
| Q37392596 | Small ubiquitin-like modifiers in cellular malignancy and metastasis |
| Q33649507 | The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer |
| Q27865256 | The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition |
| Q36225738 | The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. |
| Q52730181 | The post-translational modification, SUMOylation, and cancer (Review). |
| Q35706611 | The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion |
| Q27667579 | The role of Co2+in the crystallization of human SENP1 and comments on the limitations of automated refinement protocols |
| Q37660872 | Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells. |
| Q28484018 | Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression |
| Q35538436 | Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells |
Search more.